Caring for patients using mitragynine-derived substances
Familiarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan (Profile).
Claim CME for this episode at curbsiders.vcuhealth.org!
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.
Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME!
Credits
Written and Produced, with Show Notes, Infographic, and Cover Art by Zina Huxley-Reicher, MD
Hosts: Carolyn Chan, MD. MHS and Zina Huxley-Reicher, MD
Reviewer: Kento Sonoda, MD, MPH
Showrunner: Carolyn Chan, MD, MHS
Technical Production: PodPaste
Guest: Jonathan Tanawan, MD
Show Segments
Intro, disclaimer, guest bio
Guest one-liner, Picks of the Week*
Case from Kashlak; Definitions
Pharmacology of kratom and other mitragynine-based compounds
How to take a mitragynine-specific substance use history
Defining a use disorder
Withdrawal from kratom
Managing a use disorder with MOUD
Legal landscape and regulation
Outro
Sponsor: Freed
Go to freed.ai and use code FREED50 for fifty dollars off your first month.
Sponsor: Figs
Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.
Sponsor: Continuing Education Company
Visit CMEmeeting.org/curbsiders and use promo code Curb30 for 30% off all online courses and webcasts.